Should You Accumulate Titan Pharmaceuticals, Inc. common stock (TTNP) Stock Thursday?

Thursday, November 17, 2022 11:11 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Titan Pharmaceuticals, Inc. common stock (TTNP) Stock Thursday?

Titan Pharmaceuticals, Inc. common stock (TTNP) stock has fallen -42.31% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives TTNP stock a score of 31 out of a possible 100.

That rank is influenced by a long-term technical score of 23. TTNP's rank also includes a short-term technical score of 70.

TTNP has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on TTNP!

See Full TTNP Report

What's Happening with TTNP Stock Today

Titan Pharmaceuticals, Inc. common stock (TTNP) stock has fallen -6.21% while the S&P 500 has fallen -1.11% as of 11:00 AM on Thursday, Nov 17. TTNP has fallen -$0.06 from the previous closing price of $0.96 on volume of 2,404 shares. Over the past year the S&P 500 is down -16.51% while TTNP has fallen -42.31%. TTNP lost -$0.87 per share in the over the last 12 months. Click Here to get the full Stock Report for Titan Pharmaceuticals, Inc. common stock stock.